GAMMA Investing »

Rapport Therapeutics shares owned by GAMMA Investing

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2025-09-30 $11k 354 29.70
2025-06-30 $5.1k 445 11.37
2025-03-31 $9.2k 918 10.03
2024-12-31 $177 10 17.70

More positions owned by GAMMA Investing

Nvidia Corporation Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Amazon Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Meta Platforms Inc Cl A Common Stock (META)
Jpmorgan Chase Common Stock (JPM)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Tesla Common Stock (TSLA)
Ishares Inc Core Msci Emkt Etf (IEMG)
Berkshire Hathaway Inc Del Cl B Common Stock (BRK.B)
Ishares Tr Shrt Nat Mun Etf Etf (SUB)
Visa Inc Com Cl A Common Stock (V)
Ishares Tr National Mun Etf Etf (MUB)

View all positions for GAMMA Investing

Top funds holding Rapport Therapeutics

TRV GP V
FMR
Arch Venture Corp
Capital Research and Management Company - Division 3
Cormorant Asset Management
Goldman Sachs Group
Sofinnova Ventures
Johnson & Johnson
Vanguard Group
BlackRock
Baker Bros. Advisors
Siren
Trv Gp Vi
Vestal Point Capital
Polar Capital Holdings

View all funds holding Rapport Therapeutics